Atrial and Ventricular Fibrillation

Mechanisms and Device Therapy, Volume 9

Inbunden, Engelska, 1997

1 234 kr

Tillfälligt slut

Beskrivning

Researchers dedicated to the fundamental and clinical aspects of fibrillation and defibrillation, together with involved physicians, have exchanged their first hand research and experiences and incorporated it into this monograph which presents and reviews their latest results. The four parts of this book provide updated information on sudden cardiac death and the electrophysiology of atrial and ventricular fibrillation. Special consideration is given to device therapy, with the goal of providing the reader with useful information for the decision-making process in medical practice. This book should become a standard reference item to clinics worldwide where therapy for fibrillation is being carried out. It contains essential information of the use of ICD implants including instructions on titration and follow-up. It should be a basic text for this area of medical endeavour.

Produktinformation

Utgivningsdatum:1997-01-15
Mått:185 x 259 x 33 mm
Vikt:1 157 g
Format:Inbunden
Språk:Engelska
Antal sidor:416
Förlag:John Wiley and Sons Ltd
ISBN:9780879936501

Utforska kategorier

Mer om författaren

Maurits Allessie is an emeritus professor of physiology at Maastricht University. As an electrophysiologist he developed better insights in atrial fibrillation. Martin Fromer is the editor of Atrial and Ventricular Fibrillation: Mechanisms and Device Therapy, Volume 9, published by Wiley.

Innehållsförteckning

Preface. M.A. Allessie, M. Fromer.Foreword.E.E. Bakken..Part I. Sudden Cardiac Death.1. The Pathologist's View on Sudden Cardiac Death.A.E. Becker.2. Animal Models for the Study of Sudden Cardiac Death and Their Applicability to Clinical Cardiology.P.J. Schwartz, E. Vanoli.3. New Insights into the Mechanisms of Sudden Cardiac Death Gained by Noninvasive Means.Ph. Coumel, A. Leenhardt, X. Jouven, O. Thomas.4. Sudden Cardiac Death: A Continuing Challenge.H.J.J. Wellens, J. De Vreede, A.P.M. Gorgels..Part II. Ventricular Fibirillation and Defibrillation.5. Mapping of Ventricular Fibrillation.R.E. Ideker, G.P. Walcott, K.T. Walcott, B.H. KenKnight, E.E. Johnson, R.E. Hillsley, P.V. Bayly.6. New Insights into the Onset and Maintenance of Ventricular Fibrillation.M.J. Janse.7. The Role of Ventricular Dilatation in Ventricular Fibrillation.M.J. Reiter.8. The Electrophysiology of Ventricular Defibrillation: Today and Yesterday.S.M. Dillon.9. Prevention and Termination of Ventricular Tachycardia and Fibrillation by Drugs and Antitachycardia Pacing.M. Shenasa, H. Shenasa..Part III. Atrial Fibrillation and Defibrillation.10. Mapping of Atrial Fibrillation in Humans.M.A. Allessie, K.T.S. Konings.11. Termination of Atrial Fibrillation by Drugs.S. Nattel, Z. Wang, L.C. Pelletier, M. Carrier, C. Meere, R. Cartier.12. Electrical Remodeling Due to Atrial Fibrillation.M.C.E.F. Wijffels, C.J.H.J. Kirchhof, R. Dorland, M.A. Allessie.13. Electrical Conversion of Atrial Fibrillation.J.M. Power, M.C.E.F. Wijffels, J. Kalman, A. Tonkin, M.A. Allessie.14. Transvenous Atrial Defibrillation in Humans.F.D. Murgatroyd..Part IV. Clinical Aspects of ICD Therapy.15. Reflections on ICD Indications.J. Almendral, J.P. Villacastin, A. Arenal, J.L. Merino, L. Tercedor, J.L. Delcan.16. Learning From ICD Failures.E. Rowland, F. Hintringer.17. Prevention of ICD Complications.M. Block, D. Hammel, D. Bänsch, D. Böcker, J. Brunn, M. Weber, M. Borggrefe, H.H. Scheld, G. Breithardt.18. Quality of Life, Psychological, and Social Aspects in Patients with Implantable Cardioverter-Defibrillators.W. Jung, A. Deister, B. Lüderitz.19. Clinical Outcome of ICD Therapy.M. Fromer..Part V. Fundamental Aspects of ICD Therapy.20. The View of a Biometrician on ICD Studies.V.W. Rahlfs.21. Defibrillator Implant Criteria Based on Probability of Successful Defibrillation.P.J. DeGroot, T.R. Church, R. Mehra.22. Defibrillator Physics for the Clinician.F.W. Lindemans.23. Sensing and Detection of Tachyarrhythmias by the ICD.W.H. Olson